These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11276369)

  • 1. Prior cryopreservation of ex vivo-expanded cord blood cells is not detrimental to engraftment as measured in the NOD-SCID mouse model.
    Rice AM; Wood JA; Milross CG; Collins CJ; Case J; Nordon RE; Vowels MR
    J Hematother Stem Cell Res; 2001 Feb; 10(1):157-65. PubMed ID: 11276369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Engraftment of ex vivo expanded mononuclear cells from human umbilical cord blood in NOD/SCID mice].
    Xu L; Lin JY; Mao P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1243-6. PubMed ID: 18088476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
    Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
    Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells.
    Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M
    J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells.
    Schipper LF; Brand A; Fibbe WE; Van Hensbergen Y
    Stem Cells; 2012 May; 30(5):988-96. PubMed ID: 22378601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells.
    Bruno S; Gunetti M; Gammaitoni L; Perissinotto E; Caione L; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Stem Cells; 2004; 22(2):135-43. PubMed ID: 14990853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.
    van der Garde M; Brand A; Slot MC; de Graaf-Dijkstra A; Zwaginga JJ; van Hensbergen Y
    Stem Cells Dev; 2015 Jun; 24(12):1448-56. PubMed ID: 25668618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
    Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
    Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
    Du Z; Wang Z; Zhang W; Cai H; Tan WS
    Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells.
    Xu R; Reems JA
    Transfusion; 2001 Feb; 41(2):213-8. PubMed ID: 11239225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.